Skip to content

Use of an Ocular Telemetry Sensor in Diamox Treated Patients

Detection of IOP Fluctuation With SENSIMED Triggerfish in Patients With Glaucoma or Ocular Hypertension Treated With Diamox

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01028664
Enrollment
20
Registered
2009-12-09
Start date
2009-12-31
Completion date
2010-10-31
Last updated
2010-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Ocular Hypertension

Keywords

Glaucoma and ocular hypertension patients

Brief summary

A soft contact lens integrating a Sensor is placed on subjects with high intraocular pressure (IOP) after administration of an IOP-lowering drug to investigate the device's capacity to detect the induced IOP reduction.

Interventions

2-hour continuous IOP monitoring

Sponsors

Clinique de Montchoisi, Lausanne, Switzerland
CollaboratorUNKNOWN
Sensimed AG
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of glaucoma or ocular hypertension * IOP of ≥ 15 mmHg. * Patients of either gender. * Older than 18 years. * Patients who accept signing an informed consent approved by the Ethics Committee.

Exclusion criteria

* Patients not able to understand the nature of the research * Patients under tutorship * Corneal abnormalities in both eyes * Subjects with contraindications for wearing contact lenses * History of ocular surgery within the last 3 months * Known hypersensitivity to Diamox® or to any of its excipients * Pregnancy and lactation * Simultaneous participation in other clinical research * Patients with evidence of ocular infection or inflammation * History of renal or hepatic impairment, hypokalemia and hyponatremia

Design outcomes

Primary

MeasureTime frame
Detection of IOP reduction 2 hours after Diamox administration2 hours

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026